SCHEMBL27166273

SCHEMBL27166273

CCOCCOCCOc1ccc(C[C@H]2CN2Cc2ccc(OC)cc2)nc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.37
APP P05067 2/20 0.37
HRH2 P25021 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
DRD4 P21917 1/20 0.35
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30804770 1.00 SIGMAR1 (0.37) SIGMAR1APPHRH2HDAC3HDAC4
SCHEMBL27166244 0.87 APP (0.44) SIGMAR1APPHRH2LMNAMAPK1
SCHEMBL27166262 0.87 APP (0.44) SIGMAR1APPHRH2LMNAMAPK1
SCHEMBL27166231 0.86 SIGMAR1 (0.56) SIGMAR1HRH2LMNAMAPK1
SCHEMBL27166275 0.85 SIGMAR1 (0.42) SIGMAR1APPHRH2LMNAMAPK1
SCHEMBL27166296 0.78 APP (0.45) SIGMAR1APPHRH2DRD4
SCHEMBL27166277 0.78 APP (0.45) SIGMAR1APPHRH2DRD4
SCHEMBL27268645 0.78 APP (0.45) SIGMAR1APPHRH2DRD4
SCHEMBL27166287 0.74 SIGMAR1 (0.50) SIGMAR1
SCHEMBL27166251 0.74 LMNA (0.49) SIGMAR1HRH2LMNAMAPK1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024052549-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING BAYER AKTIENGESELLSCHAFT (DE) 2024-03-14 WO disclosed
WO-2024052549-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING BAYER AKTIENGESELLSCHAFT (DE) 2024-03-14 WO disclosed
EP-4335840-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING Bayer Aktiengesellschaft (DE) 2024-03-13 EP disclosed